Mostrando 10 resultados de: 15
Filtros aplicados
Subtipo de publicación
Other(15)
Área temáticas
Ganadería(9)
Enfermedades(8)
Microorganismos, hongos y algas(8)
Farmacología y terapéutica(7)
Medicina forense; incidencia de enfermedades(3)
Origen
google(15)
Assessment of the monoterpene, glycidic and triterpene-moieties’ contributions to the adjuvant function of the CP05 saponin of Calliandra pulcherrima Benth during vaccination …
OtherAbstract: The CP05 saponin from Calliandra pulcherrima Benth, shows remarkable similarities to the QS21 saponiPalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleA phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN)
OtherAbstract: Protection against canine kala-azar was investigated in naturally exposed dogs of an endemic area, vPalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleAcylated and deacylated saponins of Quillaja saponaria mixture as adjuvants for the FML-vaccine against visceral leishmaniasis
OtherAbstract: The adjuvant of the FML-vaccine against murine and canine visceral leishmaniasis, the Riedel de HaenPalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleEffective immunotherapy against canine visceral leishmaniasis with the FML-vaccine
OtherAbstract: The potential effect of the fucose mannose ligand (FML)-vaccine on immunotherapy of canine visceralPalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleNucleoside hydrolase DNA vaccine against canine visceral leishmaniasis
OtherAbstract: The Nucleoside Hydrolase (NH36) is the main marker of the FML complex of Leishmania donovani, antigePalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleNucleoside hydrolase from Leishmania (L.) donovani is an antigen diagnostic for visceral leishmaniasis
OtherAbstract: In this study, we have isolated a gene encoding the nucleoside hydrolase (NH) of Leishmania (L.) donPalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleImmunogenicity assay of the Leishmune® vaccine against canine visceral leishmaniasis in Brazil
OtherAbstract: Leishmune® is the industrialized version of the FML-saponin vaccine which has been shown to developPalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleImmunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune® vaccine
OtherAbstract: In order to assess the immunotherapeutic potential on canine visceral leishmaniasis of the LeishmunePalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleImmunotherapy against visceral leishmaniasis with the nucleoside hydrolase-DNA vaccine of Leishmania donovani
OtherAbstract: The nucleoside hydrolase (NH36) of Leishmania (L.) donovani is a vital enzyme which releases purinesPalabras claves:Autores:Gulnara Borja-CabreraFuentes:googleImmunotherapy with the saponin enriched-Leishmune® vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis
OtherAbstract: Leishmune®, the first licensed vaccine for prophylaxis against canine visceral leishmaniasis (CVL) aPalabras claves:Autores:Gulnara Borja-CabreraFuentes:google